CRNX
Crinetics Pharmaceuticals Inc
NASDAQ: CRNX · HEALTHCARE · BIOTECHNOLOGY
$38.44
+0.76% today
Updated 2026-04-29
Market cap
$3.99B
P/E ratio
—
P/S ratio
519.04x
EPS (TTM)
$-4.95
Dividend yield
—
52W range
$26 – $58
Volume
1.1M
WallStSmart proprietary scores
34
out of 100
Grade: F
Strong Sell
Investment rating
7.3
Growth
B+7.8
Quality
B+2.5
Profitability
F6.7
Valuation
B4/9
Piotroski F-Score
Moderate
6.4
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$83.50
+117.22%
12-Month target
—
—
Intrinsic (DCF)
$74.34
Margin of safety
+35.96%
3 Strong Buy11 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Altman Z 6.35 — safe zone
+ Revenue growth 158.40% QoQ
+ 35.96% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-93.36M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $4.74M | $4.01M | $1.04M | $7.70M | $7.70M |
| Net income | $-159.95M | $-214.53M | $-298.41M | $-465.32M | $-122.81M |
| EPS | — | — | — | — | $-4.95 |
| Free cash flow | $-116.86M | $-171.00M | $-229.81M | $-383.68M | $-93.36M |
| Profit margin | -3,376.69% | -5,345.85% | -28,720.69% | -6,046.22% | — |
Peer comparison
Smart narrative
Crinetics Pharmaceuticals Inc trades at $38.44. Our Smart Value Score of 34/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 6.35, it sits in the safe zone. TTM revenue stands at $7.70M. Our DCF model estimates intrinsic value at $74.34.
Frequently asked questions
What is Crinetics Pharmaceuticals Inc's stock price?
Crinetics Pharmaceuticals Inc (CRNX) trades at $38.44.
Is Crinetics Pharmaceuticals Inc overvalued?
Smart Value Score 34/100 (Grade F, Strong Sell). DCF value $74.34.
What is the price target of Crinetics Pharmaceuticals Inc (CRNX)?
The analyst target price is $83.50, representing +117.2% upside from the current price of $38.44.
What is the intrinsic value of Crinetics Pharmaceuticals Inc (CRNX)?
Based on our DCF model, intrinsic value is $74.34, a +36.0% margin of safety versus $38.44.
What is Crinetics Pharmaceuticals Inc's revenue?
TTM revenue is $7.70M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
6.35 — safe zone.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio519.04x
ROE-40.20%
Beta0.31
50D MA$38.85
200D MA$40.58
Shares out0.10B
Float0.10B
Short ratio—
Avg volume1.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—